Gisela Schwab, President, Prod Development & Med Aff & CMO at EXELIXIS, INC. (EXEL), sold 100,000 shares at $22.50 ($2.2M) on 2021-02-17, disclosed to the SEC on 2021-02-19.
Seasonal sale ($2.2M) by President, Prod Development & Med Aff & CMO — this insider has traded EXEL in February in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $22.50 | 50,000 | $1.1M | 50.2% |
| 2 | $22.35 | 50,000 | $1.1M | 49.8% |
| Total | $22.43 avg | 100,000 | $2.2M | 100% |
| Filing → |
| EXEL | SELL | 2021-04-02 | $1.1M | — | Filing → |
| EXEL | SELL | 2020-06-05 | $2.3M | — | Filing → |
| EXEL | SELL | 2020-04-24 | $2.6M | — | Filing → |